The Swiss pharmaceutical giant Roche announced Tuesday that it will invest more than $ 50 billion in the United States in the next five years, a measure that follows following the announcement of President Donald Trump to propose tariffs on imported drugs.
The United States is a critical market for the pharmaceutical industry, which represents more than half of the income of Roche’s pharmaceutical division, AFP reports.
Its Swiss competitor Novartis announced earlier this month that it plans to invest $ 23 billion in the US for five years.
As part of this investment, Roche based in Basel increases its existing footprint of more than 25,000 employees in 24 sites in eight states of the United States.
The company details the investment will include:
- Expanded and updated the manufacturing and distribution capabilities of the United States.
- A state -of -the -art gene manufacturing installation in Pennsylvania
- A new 900,000 square feet manufacturing center to support the Roche expanding portfolio of next -generation weight loss medicines (location that will be announced)
- A new manufacturing installation for continuous glucose monitoring in Indiana
- A new R&D center in Massachusetts, which conducts Vanguardia Artificial Intelligence (AI) and is served as a center for our new research and cardiovascular research and development efforts
- Significant expansion and improvement of our diagnostic R&D centers and existing pharmaceutical products in Arizona, Indiana and California
“Today’s announced investments underline our long -standing commitment to research, development and manufacturing in the United States,” said Roche Group Executive, Thomas Schinecker.
“Our investments of $ 50 billion in the next five years will lay the foundations for our next era of innovation and growth, they will benefit patients in the United States and worldwide.”
Related: Trump – Our rates have put the United States in the driver’s seat
As Breitbart News reported, these main pharmaceutical investments are only the last of an influx in the United States since Trump returned to office and began to notice, and imposing, their tariff policies.
Stargate, a joint project between Openai, Oracle and Softbank, has promised an investment of $ 500 billion in the United States, and Apple announced that it is investing $ 500 billion in the United States, which are just some of the other examples.